Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-24-000021 General Corporate
Debt relative to revenue 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
202.79% · OPTIONAL · VALID
Capex intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.84% · OPTIONAL · VALID
Operating cash generation 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
10.29% · OPTIONAL · VALID
Share-count growth 90th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.shares_outstanding
0.21% · CORE · VALID
Revenue growth 70th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
18.09% · CORE · VALID
Inventory pressure 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
50.43% · OPTIONAL · VALID
Gross margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
40.65% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
18.20% · CORE · VALID
R&D intensity 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.38% · OPTIONAL · VALID
SBC intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.75% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 54.56%
Current 202.79%
Delta 148.23% Capex Intensity Decreased
Previous 2.18%
Current 1.84%
Delta -0.33% Cash Generation Decreased
Previous 16.18%
Current 10.29%
Delta -5.89% Dilution Increased
Previous -0.17%
Current 0.21%
Delta 0.38% Growth Increased
Previous 12.19%
Current 18.09%
Delta 5.90% Inventory Pressure Increased
Previous 13.52%
Current 50.43%
Delta 36.91% Margin Decreased
Previous 41.12%
Current 40.65%
Delta -0.48% Profitability Increased
Previous 18.00%
Current 18.20%
Delta 0.20% R And D Intensity Increased
Previous 2.19%
Current 2.38%
Delta 0.19% Sbc Intensity Increased
Previous 0.72%
Current 0.75%
Delta 0.03% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.